150 related articles for article (PubMed ID: 23537824)
1. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.
Kose S; Mandiracioglu A; Senger SS; Ulu Y; Cavdar G; Gol B; Gurbuz I; Sariavci S; Nohutcu N
J Infect Public Health; 2013 Apr; 6(2):115-9. PubMed ID: 23537824
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
3. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
Koturoglu G; Kurugol Z; Turkoglu E
Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
[TBL] [Abstract][Full Text] [Related]
7. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
Savaş S; Dallar Y; Arikan I; Onde U
Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of varicella-zoster virus in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
[TBL] [Abstract][Full Text] [Related]
11. Varicella zoster virus infection occurs at a relatively young age in The Netherlands.
van Lier A; Smits G; Mollema L; Waaijenborg S; Berbers G; van der Klis F; Boot H; Wallinga J; de Melker H
Vaccine; 2013 Oct; 31(44):5127-33. PubMed ID: 23973248
[TBL] [Abstract][Full Text] [Related]
12. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
Chazan B; Colodner R; Teitler N; Chen Y; Raz R
Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
van Rijckevorsel GG; Damen M; Sonder GJ; van der Loeff MF; van den Hoek A
BMC Infect Dis; 2012 Jun; 12():140. PubMed ID: 22721551
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
17. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
[TBL] [Abstract][Full Text] [Related]
18. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing.
Vilibic-Cavlek T; Ljubin-Sternak S; Kolaric B; Kaic B; Sviben M; Kos L; Mlinaric-Galinovic G
Arch Gynecol Obstet; 2012 Oct; 286(4):901-4. PubMed ID: 22678561
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of varicella-zoster virus in the German population.
Wutzler P; Färber I; Wagenpfeil S; Bisanz H; Tischer A
Vaccine; 2001 Oct; 20(1-2):121-4. PubMed ID: 11567755
[TBL] [Abstract][Full Text] [Related]
20. High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climate.
O'Grady KA; Merianos A; Patel M; Gilbert L
Trop Med Int Health; 2000 Oct; 5(10):732-6. PubMed ID: 11044268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
